Effect on cell kill of addition of multidrug resistance modifiers cyclosporin A and PSC 833 to cytotoxic agents in chronic lymphocytic leukaemia

This publication has 24 references indexed in Scilit:

• A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants
  Published by Elsevier ,2003
• P-glycoprotein—A mediator of multidrug resistance in tumour cells
  European Journal Of Cancer, 1996
• Circumvention of P‐glycoprotein‐mediated drug resistance in human leukaemic cells by non‐immunosuppressive cyclosporin D analogue, SDZ PSC 833
  British Journal of Haematology, 1995
• Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs
  Published by Elsevier ,1994
• Clinical relevance of P-glycoprotein expression in haematological malignancies
  Leukemia Research, 1994
• Enhancement of daunorubicin accumulation, retention, and cytotoxicity by verapamil or cyclosporin A in blast cells from patients with previously untreated acute myeloid leukemia
  Blood, 1993
• Multidrug resistance in leukaemia
  Bailliere's Clinical Haematology, 1992
• Cyclosporins as drug resistance modifiers
  Biochemical Pharmacology, 1992
• B-cell chronic lymphocytic leukemia: present status and future directions. French Cooperative Group on CLL
  Blood, 1991
• Cell Surface P-Glycoprotein Associated with Multidrug Resistance in Mammalian Cell Lines
  Science, 1983